In 2020, Amor and colleagues identified urokinase plasminogen activator surface receptor (uPAR) as a specific Surface membrane target of senescent cells and designed uPAR-targeted CAR-T cells, which efficiently remove senescent cells in both in vitro and in vivo models of liver fibrosis and cancer427. Here, PLAUR is linked to Hepatic fibrosis.